MedPath

Edasalonexent

Generic Name
Edasalonexent
Brand Names
-
Drug Type
Small Molecule
Chemical Formula
C31H42N2O3
CAS Number
1204317-86-1
Unique Ingredient Identifier
AF3Z6434KS
Background

Edasalonexent is under investigation in clinical trial NCT01511900 (A Multiple Ascending Dose Study of CAT-1004 in Patients With Type 2 Diabetes).

Associated Conditions
-
Associated Therapies
-
Clinical Trials
Related News
nature.com
·

Therapeutic developments for Duchenne muscular dystrophy

Research on Duchenne muscular dystrophy (DMD) focuses on dystrophin, gene therapy, exon skipping, and novel treatments like vamorolone and ataluren. Studies highlight advancements in genetic diagnosis, therapeutic strategies, and clinical trials aiming to improve muscle function and quality of life for DMD patients.

Related Clinical Trials:

Microdystrophin Gene Transfer Study in Adolescents and Children With DMD
Safety and Tolerability of WVE-210201 in Patients With Duchenne Muscular Dystrophy
A Study to Assess Dystrophin Levels in Participants With Nonsense Mutation Duchenne Muscular Dystrophy (nmDMD)
Long-term Extension Study to Assess Vamorolone in Boys With Duchenne Muscular Dystrophy (DMD)
Study of an Investigational Drug, RO7239361 (BMS-986089), in Ambulatory Boys With DMD
Clinical Intramuscular Gene Transfer of rAAV1.CMV.huFollistatin344 Trial to Patients With Duchenne Muscular Dystrophy
Clinical Study to Evaluate the Efficacy and Safety of Givinostat in Ambulant Patients With Duchenne Muscular Dystrophy
Study of SRP-4045 (Casimersen) and SRP-4053 (Golodirsen) in Participants With Duchenne Muscular Dystrophy (DMD)
Study of DS-5141b in Patients With Duchenne Muscular Dystrophy
Study of Eteplirsen in DMD Patients
Study of Eteplirsen in Young Participants With Duchenne Muscular Dystrophy (DMD) Amenable to Exon 51 Skipping
Phase I/II Study of SRP-4053 in DMD Patients
Safety and Dose Finding Study of NS-065/NCNP-01 in Boys With Duchenne Muscular Dystrophy (DMD)
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of a Single Dose of SRP-5051 (Vesleteplirsen) in Patients With Duchenne Muscular Dystrophy (DMD)
Long-Term Outcomes of Ataluren in Duchenne Muscular Dystrophy
Registry of Translarna (Ataluren) in Nonsense Mutation Duchenne Muscular Dystrophy (nmDMD)
A Study to Evaluate the Safety and Tolerability of PF-06939926 Gene Therapy in Duchenne Muscular Dystrophy
A Gene Transfer Therapy Study to Evaluate the Safety of Delandistrogene Moxeparvovec (SRP-9001) in Participants With Duchenne Muscular Dystrophy (DMD)
A Randomized, Double-blind, Placebo-controlled Study of Delandistrogene Moxeparvovec (SRP-9001) for Duchenne Muscular Dystrophy (DMD)
Transplantation of Myoblasts to Duchenne Muscular Dystrophy (DMD) Patients
Clinical Trial of Coenzyme Q10 and Lisinopril in Muscular Dystrophies
Treatment Effect of Tamoxifen on Patients With DMD
Tamoxifen in Duchenne Muscular Dystrophy
Trial of Pamrevlumab (FG-3019), in Non-Ambulatory Participants With Duchenne Muscular Dystrophy (DMD)
Givinostat in Duchenne's Muscular Dystrophy Long-term Safety and Tolerability Study
Finding the Optimum Regimen for Duchenne Muscular Dystrophy
A Study to Assess the Efficacy and Safety of Vamorolone in Boys With Duchenne Muscular Dystrophy (DMD)
Phase 1/2 Study in Boys With Duchenne Muscular Dystrophy
Phase III Study of Edasalonexent in Boys With Duchenne Muscular Dystrophy
A Study to Assess the Efficacy and Safety of MNK-1411 in Duchenne Muscular Dystrophy
Safety Study of Flavocoxid in Duchenne Muscular Dystrophy
A Phase IIa Study of TAS-205 for Duchenne Muscular Dystrophy
Clinical Trial to Evaluate the Efficacy, Safety, and Tolerability of RO7239361 in Ambulatory Boys With Duchenne Muscular Dystrophy
A Phase III Double-blind Study With Idebenone in Patients With Duchenne Muscular Dystrophy (DMD) Taking Glucocorticoid Steroids
Phase III Study With Idebenone in Patients With Duchenne Muscular Dystrophy (SIDEROS-E)
Rimeporide in Patients With Duchenne Muscular Dystrophy
L-citrulline and Metformin in Duchenne's Muscular Dystrophy
Therapeutic Potential for Aldosterone Inhibition in Duchenne Muscular Dystrophy
Spironolactone Versus Prednisolone in DMD
A Study of CAP-1002 in Ambulatory and Non-Ambulatory Patients With Duchenne Muscular Dystrophy
Ramipril Versus Carvedilol in Duchenne and Becker Patients
Oral Ifetroban in Subjects With Duchenne Muscular Dystrophy
Safety and Efficacy of P-188 NF in DMD Patients
Nebivolol for the Prevention of Left Ventricular Systolic Dysfunction in Patients With Duchenne Muscular Dystrophy
Sunphenon Epigallocatechin-Gallate (EGCg) in Duchenne Muscular Dystrophy
Plus Epicatechin Duchenne Muscular Dystrophy in Non-ambulatory Adolescents
An Efficacy and Safety Trial of Intravenous Zoledronic Acid Twice Yearly in Osteoporotic Children Treated With Glucocorticoids
Gene Transfer Clinical Trial to Deliver rAAVrh74.MCK.GALGT2 for Duchenne Muscular Dystrophy
© Copyright 2025. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy